Difference between revisions of "Category:Biomarker-specific pages"
Jump to navigation
Jump to search
(Created page with "A special category of disease pages that are organized within the context of a specific biomarker, such as HER2 positivity. Category:Regimen index") |
Warner-admin (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | A special category of disease pages that are organized within the context of a specific biomarker, such as HER2 | + | A special category of disease pages that are organized within the context of a specific biomarker, such as HER2 overexpression. Note that conditions that are defined by the presence of a biomarker (e.g., CML) are not tagged to this page, whereas conditions that have subtypes defined by a biomarker (e.g., Ph+ ALL) are tagged to this page. |
[[Category:Regimen index]] | [[Category:Regimen index]] | ||
Latest revision as of 05:31, 10 January 2020
A special category of disease pages that are organized within the context of a specific biomarker, such as HER2 overexpression. Note that conditions that are defined by the presence of a biomarker (e.g., CML) are not tagged to this page, whereas conditions that have subtypes defined by a biomarker (e.g., Ph+ ALL) are tagged to this page.
Pages in category "Biomarker-specific pages"
The following 54 pages are in this category, out of 54 total.
A
B
- B-cell acute lymphoblastic leukemia, pediatric, Ph-positive
- B-cell acute lymphoblastic leukemia, Ph-positive
- Breast cancer, BRCA-mutated
- Breast cancer, ER and HER2 co-expressing
- Breast cancer, ER-positive
- Breast cancer, ER-positive - historical
- Breast cancer, ER-positive - null regimens
- Breast cancer, HER2-positive
- Breast cancer, HER2-positive - historical
- Breast cancer, HER2-positive - null regimens
- Breast cancer, PIK3CA-mutated
- Breast cancer, triple negative
- Breast cancer, triple negative - null regimens
C
M
- Malignant solid neoplasm, BRAF-mutated
- Malignant solid neoplasm, EGFR-mutated
- Malignant solid neoplasm, ERBB2-mutated
- Malignant solid neoplasm, ERBB3-mutated
- Malignant solid neoplasm, MSI-H or dMMR
- Malignant solid neoplasm, NTRK-mutated
- Malignant solid neoplasm, RET-mutated
- Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- Malignant solid neoplasm, TMB-H
- Melanoma, BRAF-mutated
- Melanoma, BRAF-mutated - null regimens
- Melanoma, KIT-mutated
- Melanoma, NRAS-mutated
- Myelodysplastic syndrome, IDH-mutated
N
- Non-small cell lung cancer, ALK-positive
- Non-small cell lung cancer, BRAF-mutated
- Non-small cell lung cancer, EGFR-mutated
- Non-small cell lung cancer, HER2-mutated
- Non-small cell lung cancer, KRAS-mutated
- Non-small cell lung cancer, MET-mutated
- Non-small cell lung cancer, RET-positive
- Non-small cell lung cancer, ROS1-positive